Ticker Details
Tenaya Therapeutics, Inc.
IPO Date:	June 30, 2021
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$156.36M
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.27 | 5.14%
Avg Daily Range (30 D):	$0.02 | 2.27%
Avg Daily Range (90 D):	$0.03 | 3.72%

Institutional Daily Volume
Avg Daily Volume:	1.51M
Avg Daily Volume (30 D):	1.72M
Avg Daily Volume (90 D):	2.91M

Trade Size
Avg Trade Size (Sh.):	318
Avg Trade Size (Sh.) (30 D):	320
Avg Trade Size (Sh.) (90 D):	430

Institutional Trades
Total Institutional Trades:	114
Avg Institutional Trade:	$1.6M
Avg Institutional Trade (30 D):	$.5M
Avg Institutional Trade (90 D):	$.74M
Avg Institutional Trade Volume:	.48M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$2.84M
Avg Closing Trade (30 D):	$.5M
Avg Closing Trade (90 D):	$.74M
Avg Closing Volume:	725.4K

News

Mar 5, 2026 @ 6:35 PM Tenaya Therapeutics Stock Jumps After New Alnylam ... Source: Vandana Singh

Nov 8, 2025 @ 4:25 PM Tenaya Therapeutics Presents Promising Interim Cli... Source: Tenaya Therapeutics

Aug 31, 2025 @ 2:15 PM Tenaya Therapeutics Presents Interim Data from MyC... Source: Tenaya Therapeutics

Mar 4, 2025 @ 3:55 PM 2025 Market Prospects of Adeno-Associated Virus Ve... Source: Researchandmarkets.Com

Jun 27, 2024 @ 9:00 PM Tenaya Therapeutics Announces Research Leadership ... Source: Tenaya Therapeutics, Inc.

Financials
	TTM	Q2 2026	Q1 2026
Basic EPS	$-.52	$-.2	$-.09
Diluted EPS	$-.52	$-.2	$-.09
Revenue	$1.34M	$1.11M	$.23M
Gross Profit
Net Income / Loss	$-103.12M	$-43.39M	$-19.27M
Operating Income / Loss	$-105.87M	$-44.09M	$-20.07M
Cost of Revenue
Net Cash Flow	$15.41M	$-2.8M	$-19.66M
PE Ratio